Advertisement Fidelity
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 17
Posts 2,861
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Navidea Biopharmaceuticals Provides Progress Updates on Lymphoseek® Programs "Business Wire" - 4/17/2014 5:30:00 PM
Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by ... "PR Newswire (US)" - 4/11/2014 7:00:00 AM
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting "Business Wire" - 4/10/2014 7:30:00 AM
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicin... "Business Wire" - 3/26/2014 7:30:00 AM
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® "Business Wire" - 3/19/2014 5:30:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/14/2014 5:00:28 PM
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence & Survival Outcomes after Sentinel Ly... "Business Wire" - 3/14/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/11/2014 5:21:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/11/2014 5:14:04 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/7/2014 4:39:26 PM
Navidea Announces Fourth Quarter and Full Year 2013 Results "Business Wire" - 3/6/2014 7:30:00 AM
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC "Business Wire" - 3/6/2014 7:00:00 AM
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling "Business Wire" - 3/5/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 "Business Wire" - 3/3/2014 2:18:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/19/2014 11:08:56 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 2/19/2014 11:05:46 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/19/2014 9:21:47 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/18/2014 4:55:22 PM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 2/18/2014 9:18:21 AM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 6309 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist